Presented by

Richard Sear, Partner, SVP, and Chief Solutions Architect, Frost & Sullivan

About this talk

Beyond pure healthcare monitoring, what elements will truly enable personalized and predictive healthcare and improve treatment outcomes? Digital biomarkers will change the way we manage our health. They will increasingly transform how we use our healthcare data and improve clinical decision-making and care outcomes. As we shift toward a more digitally powered health system, digital biomarkers will play a key role in changing the healthcare approach from reactive to preventative. This technology shows tremendous potential in making predictive and personalized healthcare a reality.

Related topics:

More from this channel

Upcoming talks (2)
On-demand talks (35)
Subscribers (34327)
Frost & Sullivan’s emerging market experts and economic research and analysis teams are partnering with clients to help provide the navigational tools to chart out a pipeline of economic growth opportunities. Navigating economic and geo-political risks, while capitalizing on the opportunities is the essential value proposition of the Emerging Markets Innovation program.